+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

2021 IVD Market Update and COVID-19 Impact

  • Report

  • 54 Pages
  • March 2021
  • Region: Global
  • Kalorama Information
  • ID: 5315014
Description Jump to:
What is the Size of the IVD Market in 2021? What Impact has COVID-19 Had on IVD Markets? What Major Trends are Affecting the Market in 2021?

Diagnostic test products have never been more important. This report, 2021 IVD Market Update and COVID-19 Impact, is an update of the market for in vitro diagnostics products from the report's analysts to reflect the latest information.

As part of its coverage, this report contains market sizing for the following categories of IVD:


  • Clinical Chemistry
  • Immunoassays - non isotopic
  • Infectious disease
  • Other immunos
  • Blood bank screening
  • Drugs of Abuse
  • Diabetes HbA1c - lab
  • Hematology - Core Lab
  • Microbiology (ID/AST)
  • Microbiology (molecular)
  • Microbiology - Mass Spectrometry
  • Radioimmunoassays
  • Coagulation (PT/INR)
  • Coagulation, molecular
  • Histology/cytology
  • HPV, molecular
  • Nucleic acid assays
  • Blood grouping/typing
  • Blood bank molecular
  • NAT Blood Screens
  • Circulating tumor cells
  • POC, OTC diabetes
  • POC, OTC other
  • POC, professional/hospital;
  • COVID-19

Complete market figures and forecasts will be part of the Worldwide report in August.

How is COVID-19 Impacting the Market in 2021


This report does detail the effects of COVID-19 including the following:


  • Effect of COVID-19 on Market Segments
  • Table 1-3: IVD Market excluding and with COVID-19, 2020
  • Figure 1-1: IVD Market Distribution by Segment
  • Table 1-4: Global In Vitro Diagnostic Market - YoY Growth 2019-2020
  • Figure 1-2: Global In Vitro Diagnostic Market - YoY Growth 2019-2020
  • Figure 1-3: IVD Segment Performance, Q1 2020 - Q4 2020
  • Figure 1-4: IVD Segment Performance, Total Market Value, 2020

Also included in this report:


  • Product Trends and Developments
  • COVID-19 Developments Sept. 2020 to Feb 2021
  • Select IVD Market Participant Developments
  • Competitive Leader Updates

Table of Contents

ONE: WORLDWIDE IVD MARKET - 2020 UPDATE
  • Table 1-1: Global In Vitro Diagnostic Sales by Product Market, 2020 ($ million) (Clinical Chemistry; Immunoassays- non isotopic: Infectious disease, Other immunos, Blood bank screening, Drugs of Abuse, Diabetes HbA1c - lab; Hematology - Core Lab; Microbiology (ID/AST); Microbiology (molecular); Microbiology - Mass Spectrometry; Radioimmunoassays; Coagulation (PT/INR); Coagulation, molecular; Histology/cytology; HPV, molecular; Nucleic acid assays; Blood grouping/typing; Blood bank molecular - NAT Screens; Circulating tumor cells; POC, OTC diabetes; POC, OTC other; POC, professional/hospital; Mass Spectrometry)


COVID 19
  • Table 1-2: COVID-19 Product Sales - Immunoassay (Antigen, Serology), Molecular, POC), 2020 ($ millions)


IVD MARKET HIGHLIGHTS AND EFFECTS OF COVID-19
  • Effect of COVID-19 on Market Segments
    • Table 1-3: IVD Market excluding and with COVID-19, 2020
    • Figure 1-1: IVD Market Distribution by Segment
    • Table 1-4: Global In Vitro Diagnostic Market - YoY Growth 2019-2020
    • Figure 1-2: Global In Vitro Diagnostic Market - YoY Growth 2019-2020
    • Figure 1-3: IVD Segment Performance, Q1 2020 - Q4 2020
    • Figure 1-4: IVD Segment Performance, Total Market Value, 2020



TWO: PRODUCT TRENDS AND NEW DEVELOPMENTS
  • NEW CORE IVD PRODUCT LAUNCHES AND DEVELOPMENTS
    • Clinical Chemistry
    • Hematology
    • Oncology
    • Coagulation
    • Immunoassay
    • Microbiology
    • Histology
    • Molecular Specialties
    • POC
    • Mass Spectrometry

  • COVID-19 DEVELOPMENTS - SEPTEMBER 2020 - FEBRUARY 2021
    • Figure 2-1: COVID-19 Test Market by Type, Q1-Q4 2020 - Increasing Performance in Antigen and Rapid testing; Molecular Maintains Growth; Serology Runs Steady

  • Antigen
  • Serology
  • Molecular


THREE: SELECTED IVD MARKET PARTICIPANT DEVELOPMENTS
  • SELECTED COMPETITIVE LEADER UPDATES
    • Figure 3-1: IVD Segment Growth by Leading Competitors, Change in Sales 2019-2020
    • Figure 3-2: Changes in Market Distribution for IVD Sales, 2019-2020 - Roche Maintains Lead, Abbott Closing Gap

  • ABBOTT
    • Table 3-1: Abbott Corporate Summary

  • AIDIAN OY
    • Table 3-2: Aidian Oy Summary

  • BECTON DICKINSON AND CO
    • Table 3-3: BD Corporate Summary

  • BIOMÉRIEUX SA
    • Table 3-4: bioMerieux Corporate Summary

  • DANAHER
    • Table 3-5: Danaher Corporation Summary

  • HOLOGIC, INC.
    • Table 3-6: Hologic Corporate Summary

  • ILLUMINA
    • Table 3-7: Illumina Corporate Summary

  • ORTHO CLINICAL DIAGNOSTICS
    • Table 3-8: Ortho Clinical Corporate Summary

  • PERKIN ELMER
    • Table 3-9: Perkin Elmer Corporate Summary

  • QUIDEL CORPORATION
    • Table 3-10: Quidel Corporate Summary

  • ROCHE DIAGNOSTIC
    • Table 3-11: Roche Diagnostic Corporate Summary

  • THERMO FISHER SCIENTIFIC
    • Table 3-12: Thermo Fisher Scientific Corporate Summary



FOUR: NEW OPPORTUNITIES
  • TELEHEALTH AND REMOTE PATIENT MONITORING
  • EXPANDING OPTIONS IN REIMBURSEMENT
  • POC

Samples

Loading
LOADING...

Companies Mentioned

  • Abbott
  • Aidian Oy
  • Becton Dickinson and Co
  • Biomérieux SA
  • Danaher
  • Hologic, Inc.
  • Illumina
  • Ortho Clinical Diagnostics
  • Perkin Elmer
  • Quidel Corporation
  • Roche Diagnostic
  • Thermo Fisher Scientific

Related Topics

Related Reports

In Vitro Diagnostic (IVD) Trends and Market Update: March 2024 - Product Image

In Vitro Diagnostic (IVD) Trends and Market Update: March 2024

  • Report
  • 55 Pages
  • Global
From
The Worldwide Market for In Vitro Diagnostic Tests, 16th Edition - Product Image

The Worldwide Market for In Vitro Diagnostic Tests, 16th Edition

  • Report
  • 1500 Pages
  • Global
From
In-Vitro Diagnostics Market by Offering (Kits, Software), Technology (Immunoassay, Molecular Diagnostics [PCR, NGS, Microarray], Rapid Tests, Biochemistry), Application (Infectious Diseases, Oncology), Diagnostic Approach (Lab, POC) - Global Forecast to 2030 - Product Image

In-Vitro Diagnostics Market by Offering (Kits, Software), Technology (Immunoassay, Molecular Diagnostics [PCR, NGS, Microarray], Rapid Tests, Biochemistry), Application (Infectious Diseases, Oncology), Diagnostic Approach (Lab, POC) - Global Forecast to 2030

  • Report
  • 526 Pages
  • Global
From
Global In Vitro Diagnostics Market by Product & Service (Instruments, Kits, Software), Technology (Immunoassay, Hematology, Urinalysis), Specimen (Blood, Saliva), Test Type, Application (Oncology, Autoimmune, CVD, Infectious Diseases) - Forecast to 2029 - Product Image

Global In Vitro Diagnostics Market by Product & Service (Instruments, Kits, Software), Technology (Immunoassay, Hematology, Urinalysis), Specimen (Blood, Saliva), Test Type, Application (Oncology, Autoimmune, CVD, Infectious Diseases) - Forecast to 2029

  • Report
  • 677 Pages
  • Global
From
In Vitro Diagnostic (IVD) Reagents Market by Type (Antibodies, Proteins, Oligonucleotides, Nucleic Acid Probes) Technology (Immunoassay, Biochemistry, Molecular Diagnostic, Microbiology, Hematology) Use (Clinical, RUO) End User - Global Forecast to 2030 - Product Image

In Vitro Diagnostic (IVD) Reagents Market by Type (Antibodies, Proteins, Oligonucleotides, Nucleic Acid Probes) Technology (Immunoassay, Biochemistry, Molecular Diagnostic, Microbiology, Hematology) Use (Clinical, RUO) End User - Global Forecast to 2030

  • Report
  • 389 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.